WE
WELL.LSE Hanetf Icav - Han-Gins Healthcare Innovation Ucits ETF
- USD
No recent price
- Total assets
- 13.5M
- Expense ratio
- 0.87%
- Dividend yield
- -
- 1-year return
- +8.79%
- Holdings
- 45
- Since
- 2019
Fund data as reported by the issuer, updated Nov 4, 2026. Total assets are in the fund's base currency.
What does WELL.LSE invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (94.2%)
- Largest sector: Healthcare (100.0%)
- Largest region: North America (98.0%)
- Top 3 holdings: 23.1% of the fund
Asset allocation
- US stocks 94.2%
- Non-US stocks 4.9%
- Cash 2.7%
Top holdings
- Eli Lilly and Company 9.26%
- Ascendis Pharma AS 9.03%
- argenx NV ADR 4.83%
- Natera Inc 4.68%
- Insmed Inc 4.21%
Hanetf Icav - Han-Gins Healthcare Innovation Ucits ETF performance
Sharpe ratio 0.52- This year
- +6.76%
- 1 year
- +8.79%
- 3 years
- +11.37%
- 5 years
- -5.59%
Volatility 17.9% over 1 year and 18.7% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
WELL.LSE price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Hanetf Icav - Han-Gins Healthcare Innovation Ucits ETF top holdings
49.9% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Eli Lilly and Company LLY.US | Healthcare | United States | 9.26% |
| Ascendis Pharma AS ASND.US | Healthcare | United States | 9.03% |
| argenx NV ADR ARGX.US | Healthcare | United States | 4.83% |
| Natera Inc NTRA.US | Healthcare | United States | 4.68% |
| Insmed Inc INSM.US | Healthcare | United States | 4.21% |
| Vaxcyte Inc PCVX.US | Healthcare | United States | 4.16% |
| Revolution Medicines Inc RVMD.US | Healthcare | United States | 3.71% |
| Rhythm Pharmaceuticals Inc RYTM.US | Healthcare | United States | 3.71% |
| Guardant Health Inc GH.US | Healthcare | United States | 3.48% |
| UnitedHealth Group Incorporated UNH.US | Healthcare | United States | 2.87% |
The 10 largest of 45 holdings.
WELL.LSE sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
WELL.LSE regional exposure
- North America98.0%
- Europe Developed3.1%
Share of the stocks in the fund.
Company size
Average market cap 32.7B- Mega cap9.3%
- Big cap14.4%
- Medium cap31.5%
- Small cap36.1%
- Micro cap3.4%
Hanetf Icav - Han-Gins Healthcare Innovation Ucits ETF fund profile
- Fund name
- Hanetf Icav - Han-Gins Healthcare Innovation Ucits ETF
- Ticker
- WELL.LSE
- Exchange
- London Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Ireland
- Inception date
- Apr 4, 2019
- Trading currency
- USD
- Expense ratio
- 0.87%